Volume 82, Issue 6 pp. 900-909
Original Article

Inflammation but not obesity or insulin resistance is associated with increased plasma fibroblast growth factor 23 concentration in the elderly

Michał Holecki

Corresponding Author

Michał Holecki

Department of Internal Medicine and Metabolic Diseases, School of Health Sciences, Medical University of Silesia, Katowice, Poland

Correspondence: Michal Holecki, Department of Internal Medicine and Metabolic Diseases, Medical University of Silesia, Ziołowa 45-47, 40-635 Katowice, Poland. Tel.: +48323598223; E-mail: [email protected]Search for more papers by this author
Jerzy Chudek

Jerzy Chudek

Pathophysiology Unit, Department of Pathophysiology, Medical Faculty in Katowice, Medical University of Silesia, Katowice, Poland

Department of Nephrology, Transplantation and Internal Medicine, Medical Faculty in Katowice, Medical University of Silesia, Katowice, Poland

Search for more papers by this author
Aleksander Owczarek

Aleksander Owczarek

Division of Statistics, Department of Instrumental Analysis, Faculty of Pharmacy and Laboratory Medicine in Sosnowiec, Medical University of Silesia, Katowice, Poland

Search for more papers by this author
Magdalena Olszanecka-Glinianowicz

Magdalena Olszanecka-Glinianowicz

Health Promotion and Obesity Management Unit, Department of Pathophysiology, Medical Faculty in Katowice, Medical University of Silesia, Katowice, Poland

Search for more papers by this author
Maria Bożentowicz-Wikarek

Maria Bożentowicz-Wikarek

Pathophysiology Unit, Department of Pathophysiology, Medical Faculty in Katowice, Medical University of Silesia, Katowice, Poland

Search for more papers by this author
Jan Duława

Jan Duława

Department of Internal Medicine and Metabolic Diseases, School of Health Sciences, Medical University of Silesia, Katowice, Poland

Search for more papers by this author
Małgorzata Mossakowska

Małgorzata Mossakowska

International Institute of Molecular and Cell Biology, Warsaw, Poland

Search for more papers by this author
Tomasz Zdrojewski

Tomasz Zdrojewski

Department of Arterial Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland

Search for more papers by this author
Anna Skalska

Anna Skalska

Department of Internal Medicine and Gerontology, Jagiellonian University Medical College, Krakow, Poland

Search for more papers by this author
Andrzej Więcek

Andrzej Więcek

Department of Nephrology, Transplantation and Internal Medicine, Medical Faculty in Katowice, Medical University of Silesia, Katowice, Poland

Search for more papers by this author
First published: 03 March 2015
Citations: 46

Summary

Background

Fibroblast growth factor 23 (FGF23) is a hormone involved in calcium–phosphate homoeostasis. The data of recently published studies suggest that FGF-23 may also play a role in some metabolic processes beyond mineral metabolism, such as insulin resistance or energy homoeostasis. The aim of the study was to attempt the relationships between plasma cFGF-23 (C-terminal) and iFGF-23 (intact) concentrations and the occurrence of obesity, insulin resistance and inflammation in elderly population.

Materials and methods

The analysis included 3115 elderly subjects (1485 women). During three visits, a questionnaire survey, comprehensive geriatric assessment and anthropometric measurements were performed as well as blood and urine samples were collected by trained nurses. Serum phosphorus, calcium, intact parathormone (iPTH), 25(OH)D3, iFGF-23 and cFGF-23, insulin, glucose, albumin (also in urine), creatinine, hs-CRP, interleukin-6 and NT-proBNP concentrations were assessed. HOMA-IR was calculated according to the standard formula.

Results

Both forms of FGF23, iPTH and 25-OH-D3 levels were not related to the occurrence of obesity and insulin resistance. Increase in phosphorus, iPTH and NT-proBNP concentrations is associated with rise in plasma iFGF23 and cFGF23 levels. Additionally, increase in hs-CRP explained the elevated plasma iFGF23 levels.

In multiple regression models, circulating iFGF23 and cFGF23 level's variability in elderly population were explained by changes in serum phosphorus, iPTH, eGFR, hs-CRP and NT-proBNP levels but not by BMI and HOMA-IR values.

Conclusion

In conclusion, our study shows that increased levels of both circulating Fibroblast growth factor 23 forms in elderly subjects are associated with inflammation but not obesity or insulin resistance per se.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.